Revenue + Forward P/E
Insmed Incorporated (INSM) quarterly revenue and forward P/E
RevenueRevenue (est)Forward P/E
Valuation
Market cap
$27.46B
Enterprise value
$23.39B
P/E ratio (TTM)
-18.64x
P/S ratio (TTM)
28.34x
P/B ratio
32.76x
EV/Sales
28.55x
EV/EBITDA
-21.64x
Dividend yield
0.00%
Income statement (TTM)
Revenue (TTM)
$606.42M
Gross profit (TTM)
$481.55M
Operating income (TTM)
$-1.18B
EBITDA (TTM)
$-1.17B
Net income (TTM)
$-1.28B
Free cash flow (TTM)
$-967.57M
Margins & returns
Gross margin
81.56%
Operating margin
-137.74%
Profit margin
-144.44%
Return on equity
-130.11%
Return on assets
-57.02%
Per-share metrics
EPS (TTM)
-$5.49
Dividend yield
0.00%
Beta
0.78
Capital structure
Cash & equivalents
$510.44M
Total debt
$768.16M
Net debt
$257.71M
Shares outstanding
216.75M
Financial health
Current ratio
3.83
Debt / equity
1.04
Debt / assets
0.34
Interest coverage
-14.04
| Company | Market cap | P/E | P/S | EV/EBITDA | Div yield |
|---|---|---|---|---|---|
| $1.15T | 42.41x | 15.59x | 34.80x | 0.54% | |
| $629.85B | 30.45x | 6.47x | 20.76x | 1.99% | |
| $443.16B | 127.13x | 7.29x | 30.82x | 2.63% | |
| $365.38B | 27.06x | 0.85x | 16.46x | 2.13% | |
| $354.73B | 23.91x | 4.80x | 15.14x | 2.67% | |
| $332.46B | 36.82x | 4.94x | 19.57x | 2.56% | |
| $27.46B | -18.64x | 28.34x | -21.64x | - |